Skip to content
Clinical Trials – home
Humanitas Mirasole S.p.A.
Sponsor

Humanitas Mirasole S.p.A.

Italy Via Alessandro Manzoni 56, 20089 Rozzano, Italy

About the sponsor

Humanitas Mirasole S.p.A. supports clinical research in diffuse large B-cell lymphoma, high-grade B-cell lymphoma, acute myeloid leukemia, and myelodysplastic syndrome, with additional work in recurrent metastatic nasopharyngeal carcinoma and hepatocellular carcinoma. The portfolio includes interest in disease settings that are refractory, relapsed, or resistant to prior treatment.

  • Relapsed/refractory lymphoma after CAR T-cell therapy
  • Acute myeloid leukemia and myelodysplastic syndrome
  • Nasopharyngeal carcinoma
  • Hepatocellular carcinoma

Research activity in this area reflects a strong focus on difficult-to-treat malignancies and post-treatment disease control.

About Specializations

Humanitas Mirasole S.p.A. runs clinical trials in conditions such as Acute myocardial infarction, Diabetes mellitus, Nasopharyngeal cancer, Head and neck cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Humanitas Mirasole S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Humanitas Mirasole S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mitazalimab
  • Sponsor:Humanitas Mirasole S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bms-986340
  • Sponsor:Humanitas Mirasole S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Monalizumab
  • Sponsor:Humanitas Mirasole S.p.A.
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Diakonhjemmet Sykehus AS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Loncastuximab Tesirine
  • Sponsor:Humanitas Mirasole S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Humanitas Mirasole S.p.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.